retatrutide news today recency 3 glp-1 What GLP‑3 Really Is: Triple‑Receptor Drug Lilly's Retatrutide Scores Triple Trial

Description

Track more than just scale weight Stop using the scale as your only metric

GLP-1 prescriptions for weight-loss In a separate analysis between 2020 and 2023, one HealthVerity closed claims dataset had more than 1.5 million patients who had at least one prescription for tirzepatide or semaglutide

The one exception to that rule is coffee, which can be drunk black with no milk or creamer

For Blue Cross, losses are likely to continue into this year, despite the insurer eliminating jobs, deploying computer algorithms to target doctors it believes are overcharging, restricting coverage of GLP-1 drugs for weight loss, and pushing back against health care providers seeking higher reimbursement rates